Edith Langevin

3.0k total citations
16 papers, 172 citations indexed

About

Edith Langevin is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Edith Langevin has authored 16 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Epidemiology. Recurrent topics in Edith Langevin's work include Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (6 papers) and Pneumonia and Respiratory Infections (5 papers). Edith Langevin is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Viral Infections and Vectors (6 papers) and Pneumonia and Respiratory Infections (5 papers). Edith Langevin collaborates with scholars based in France, United States and Canada. Edith Langevin's co-authors include Nicholas Jackson, Cameron P. Simmons, Yves Girerd-Chambaz, Kien Duong Thi Hue, Carina Frago, Betzana Zambrano, Hélène Bricout, Sabine Tong, Gustavo H. Dayan and Carlos A. DiazGranados and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Edith Langevin

14 papers receiving 172 citations

Peers

Edith Langevin

PHEOH

EPIDE

MICRO

SPS

Martina Rauscher Switzerland

Frilasita A. Yudhaputri Indonesia

Teresita Serrano Cuba

Anisone Chanthongthip Laos

Chee‐Fu Yung Singapore

Thelma Laot Philippines

Inge Lefevre Switzerland

V. Servas France

Simin Aysel Florescu Romania

Hannah R. Volkman United States

Martina Rauscher Switzerland

Edith Langevin

235 ×1.9

PHEOH

200 ×1.9

25 ×0.7

EPIDE

16 ×0.7

MICRO

22 ×1.0

SPS

Citations per year, relative to Edith Langevin Edith Langevin (= 1×) peers Martina Rauscher

Countries citing papers authored by Edith Langevin

Since Specialization

Citations

This map shows the geographic impact of Edith Langevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Langevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Langevin more than expected).

Fields of papers citing papers by Edith Langevin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Langevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Langevin. The network helps show where Edith Langevin may publish in the future.

Co-authorship network of co-authors of Edith Langevin

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Langevin. A scholar is included among the top collaborators of Edith Langevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Langevin. Edith Langevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Coudeville, Laurent, et al.. (2025). Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines. Scientific Reports. 15(1). 24990–24990.

Langevin, Edith, et al.. (2025). Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach. BMC Public Health. 25(1). 1863–1863. 1 indexed citations

Wu, Xiaotian, et al.. (2025). Risk assessment and mitigation evaluation of future yellow fever outbreaks under different climate scenarios: Insight from a case study of Brazil. PLoS neglected tropical diseases. 19(10). e0013448–e0013448.

Batram, Manuel, et al.. (2024). Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany. Infectious Diseases and Therapy. 13(4). 907–920. 2 indexed citations

Shin, Thomas, Chad R. Wells, Affan Shoukat, et al.. (2024). Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults. JAMA Network Open. 7(11). e2443551–e2443551. 4 indexed citations

Langevin, Edith, et al.. (2023). Evolution of Pneumococcal Vaccine Recommendations and Criteria for Decision Making in 5 Western European Countries and the United States. MDM Policy & Practice. 8(1). 107921184–107921184. 16 indexed citations

Poulos, Christine, et al.. (2023). HSD128 Preferences of Healthcare Providers in Switzerland for Attributes of Pediatric Hexavalent Vaccines. Value in Health. 26(12). S318–S319. 1 indexed citations

Bricout, Hélène, et al.. (2022). Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis. BMC Public Health. 22(1). 521–521. 18 indexed citations

Dayan, Gustavo H., Edith Langevin, Rémi Forrat, et al.. (2020). Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus. Vaccine. 38(41). 6472–6477. 17 indexed citations

10.

Dayan, Gustavo H., Edith Langevin, Peter B. Gilbert, et al.. (2020). Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus. Vaccine. 38(19). 3531–3536. 9 indexed citations

11.

DiazGranados, Carlos A., Edith Langevin, Matthew Bonaparte, et al.. (2020). CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals. Clinical Infectious Diseases. 72(10). 1730–1737. 8 indexed citations

12.

Zambrano, Betzana, Fernando Noriega, Gustavo H. Dayan, et al.. (2020). Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America. American Journal of Tropical Medicine and Hygiene. 104(1). 136–144. 3 indexed citations

13.

Chansinghakul, Danaya, Kriengsak Limkittikul, Arunee Sabchareon, et al.. (2019). Long-term safety follow-up of children from a randomized—controlled phase II b proof—of—concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD—TDV) in Thailand. Asian Pacific Journal of Tropical Medicine. 12(9). 396–396. 3 indexed citations

14.

Juraska, Michal, Craig A. Magaret, Jason Shao, et al.. (2018). Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials. Proceedings of the National Academy of Sciences. 115(36). 48 indexed citations

15.

Pasin, Chloé, M. Elizabeth Halloran, Peter B. Gilbert, et al.. (2018). Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease. PLoS ONE. 13(12). e0207878–e0207878. 5 indexed citations

16.

Rabaa, Maia A., Yves Girerd-Chambaz, Kien Duong Thi Hue, et al.. (2017). Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy. eLife. 6. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact